OpRisk North America: Moving OTC trades onto CCPs will increase op risks

Victoria Tozer-Pennington
01 Apr 2011

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Panellists and speakers at the OpRisk North America conference in New York were unanimous in praising the move to clear all over-the-counter products through central counterparties (CCPs) houses as a positive development. But they warn there are numerous systemic and operational risk issues attached.

Randall Kroszner, professor of economics at the University of Chicago Booth School of Business and former governor of the Federal Reserve System, described moving OTC derivatives onto central

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]